Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study (Q45031765)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study |
scientific article |
Statements
1 reference
Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study (English)
1 reference
Alain Vergnenègre
1 reference
Hervé Le Caer
1 reference
Isabelle Monnet
1 reference
Maurice Pérol
1 reference
David Pérol
1 reference
Armelle Lavolé
1 reference
Virginie Westeel
1 reference
Pierre Fournel
1 reference
Lionel Falchero
1 reference
Michel Poudenx
1 reference
Fabien Vaylet
1 reference
Fabrice Barlési
1 reference
Olivier Bylicki
1 reference
Céline Ferlay
1 reference
Cathérine Dubos
1 reference
Jacky Créquit
1 reference
Roman Corre
1 reference
Pauline Linard
1 reference
Gérald Zalcman
1 reference
1 July 2013
1 reference
1 reference
8
1 reference
7
1 reference
906-914
1 reference
Identifiers
1 reference
1 reference